Female sexual dysfunction, or FSD, has long been under-diagnosed and under-treated in clinical practice. But in recent months, notable leaders in women's health have stepped forward to push for new recognition and prioritization of this disorder to the forefront of the FDA. On this program, host Dr. Matt Birnholz is joined by one of those leaders who helped jumpstart this critical development: Dr. Michael Krychman, Executive Director of the Southern California Center for Sexual Health in Newport Beach, CA.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
The National Campaign to Recognize Female Sexual Dysfunction
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Recommended
Details
Presenters
Comments
Recommended
Sponsored by
Overview
Female sexual dysfunction, or FSD, has long been under-diagnosed and under-treated in clinical practice. But in recent months, notable leaders in women's health have stepped forward to push for new recognition and prioritization of this disorder to the forefront of the FDA. On this program, host Dr. Matt Birnholz is joined by one of those leaders who helped jumpstart this critical development: Dr. Michael Krychman, Executive Director of the Southern California Center for Sexual Health in Newport Beach, CA.
Presenters
Facebook Comments